The tool, CogniSense, has been designed to overcome limitations of conventional paper-based cognitive assessment such as lack of objective, in addition to easily track data and integrate with electronic health records (EHRs).
CogniSense will provide healthcare practitioners with a digitized version of the memory orientation assessment test (MOST) to evaluate the cognitive health of a patient's brain through the use of memory recall techniques and information comprehension tests.
The test will also use tablet-based clock drawing that provides assessment of patient's memory, orientation, sequential memory and time.
According to the company, the MOST has been shown to have greater sensitivity and specificity than standard, paper-based mini–mental state examination (MMSE) and MiniCog tests, based on studies involving more than 3,500 individuals.
CogniSense, which is available as an app Apple iPad, is administered and scored electronically.
The scores can be stored in Quest's Care360 lab-ordering platform and other 600 electronic health records that connect to Quest.
Quest Diagnostics neurology medical director Edward Ginns said: "CogniSense addresses a gap in cognitive health assessment today – a lack of digital technology that seamlessly integrates results into a patient's electronic health records to track cognitive function and disease progression over time.
"CogniSense's features enhance the efficiency and ease of cognitive assessment – especially in a primary care setting."
